HUP0300990D0 - Synergistic combination for the prophylaxis and treatment of diabetes - Google Patents

Synergistic combination for the prophylaxis and treatment of diabetes

Info

Publication number
HUP0300990D0
HUP0300990D0 HU0300990A HUP0300990A HUP0300990D0 HU P0300990 D0 HUP0300990 D0 HU P0300990D0 HU 0300990 A HU0300990 A HU 0300990A HU P0300990 A HUP0300990 A HU P0300990A HU P0300990 D0 HUP0300990 D0 HU P0300990D0
Authority
HU
Hungary
Prior art keywords
prophylaxis
diabetes
treatment
synergistic combination
synergistic
Prior art date
Application number
HU0300990A
Other languages
Hungarian (hu)
Original Assignee
Synosens Kutato Es Fejlesztoe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synosens Kutato Es Fejlesztoe filed Critical Synosens Kutato Es Fejlesztoe
Priority to HU0300990A priority Critical patent/HUP0300990A2/en
Publication of HUP0300990D0 publication Critical patent/HUP0300990D0/en
Priority to JP2006506248A priority patent/JP2006523668A/en
Priority to YUP-2005/0776A priority patent/RS20050776A/en
Priority to EP04727331A priority patent/EP1648453A1/en
Priority to PCT/HU2004/000037 priority patent/WO2004091612A1/en
Priority to CA002522126A priority patent/CA2522126A1/en
Publication of HUP0300990A2 publication Critical patent/HUP0300990A2/en

Links

HU0300990A 2003-04-15 2003-04-15 Synergistic combination for the prophylaxis and treatment of diabetes HUP0300990A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
HU0300990A HUP0300990A2 (en) 2003-04-15 2003-04-15 Synergistic combination for the prophylaxis and treatment of diabetes
JP2006506248A JP2006523668A (en) 2003-04-15 2004-04-14 Synergistic pharmaceutical combination containing cicletanine for the prevention or treatment of diabetes
YUP-2005/0776A RS20050776A (en) 2003-04-15 2004-04-14 A synergistic pharmaceutical combination comprising cicletanine for the prevention or treatment diabetes
EP04727331A EP1648453A1 (en) 2003-04-15 2004-04-14 A synergistic pharmaceutical combination comprising cicletanine for the prevention or treatment of diabetes
PCT/HU2004/000037 WO2004091612A1 (en) 2003-04-15 2004-04-14 A synergistic pharmaceutical combination comprising cicletanine for the prevention or treatment of diabetes
CA002522126A CA2522126A1 (en) 2003-04-15 2004-04-14 A synergistic pharmaceutical combination comprising cicletanine for the prevention or treatment of diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0300990A HUP0300990A2 (en) 2003-04-15 2003-04-15 Synergistic combination for the prophylaxis and treatment of diabetes

Publications (2)

Publication Number Publication Date
HUP0300990D0 true HUP0300990D0 (en) 2003-06-28
HUP0300990A2 HUP0300990A2 (en) 2005-05-30

Family

ID=90001685

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300990A HUP0300990A2 (en) 2003-04-15 2003-04-15 Synergistic combination for the prophylaxis and treatment of diabetes

Country Status (6)

Country Link
EP (1) EP1648453A1 (en)
JP (1) JP2006523668A (en)
CA (1) CA2522126A1 (en)
HU (1) HUP0300990A2 (en)
RS (1) RS20050776A (en)
WO (1) WO2004091612A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050113314A1 (en) * 2003-08-29 2005-05-26 Fong Benson M. Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome
US20050054731A1 (en) * 2003-09-08 2005-03-10 Franco Folli Multi-system therapy for diabetes, the metabolic syndrome and obesity
CA2546793A1 (en) * 2003-12-16 2005-06-30 Novartis Ag Use of stating for the treatment of metabolic syndrome
EP1804795A4 (en) * 2004-09-22 2007-11-07 Cornett Glen Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
US20080096915A1 (en) * 2005-01-13 2008-04-24 Greenberg Traurig LLP Compositions for the treatment of metabolic disorders
KR101701943B1 (en) 2009-11-13 2017-02-02 도레이 카부시키가이샤 Therapeutic or prophylactic agent for diabetes
ES2869423T3 (en) 2011-08-08 2021-10-25 Immunomet Therapeutics Inc N1-cyclic amine-N5-substituted phenylbiguanide derivatives and pharmaceutical composition comprising the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN156817B (en) * 1981-02-10 1985-11-09 Scras

Also Published As

Publication number Publication date
WO2004091612A1 (en) 2004-10-28
JP2006523668A (en) 2006-10-19
RS20050776A (en) 2007-11-15
CA2522126A1 (en) 2004-10-28
EP1648453A1 (en) 2006-04-26
HUP0300990A2 (en) 2005-05-30

Similar Documents

Publication Publication Date Title
HK1152474A1 (en) Methods and compositions for the prevention and treatment of sepsis
EP1543034A4 (en) Treatment and prophylaxis with 4-1bb-binding agents
ZA200709727B (en) Compounds and methods for the treatment of prevention of flavivirus infections
HUS2200036I1 (en) Use of dihydroimidazolones for the treatment of dogs
PL1732575T3 (en) Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
GB2418025B (en) Device for the prevention or treatment of ulcers
AU2003279442A8 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
GB0326486D0 (en) Combination treatment
IL187405A0 (en) Methods and compositions for the treatment of pain
IL178903A0 (en) Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions
HK1082923A1 (en) Synergistic compositions for the prevention and treatment of acquired immunodeficiency
HUP0300990D0 (en) Synergistic combination for the prophylaxis and treatment of diabetes
PL375564A1 (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
GB2388027B (en) Use of palatinose for the treatment of mental stress
ZA200608918B (en) Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions
EP1671648A4 (en) Prevention and treatment for gvhd
EP1660007A4 (en) Compositions for diabetes treatment and prophylaxis
IL164951A0 (en) The treatment of pain with lfendropil
AU2003291461A8 (en) Compositions for diabetes treatment and prophylaxis
EP1648469A4 (en) Antiglucocorticoids for the treatment of catatonia
GB2401044B (en) A composition for use in the treatment or prophylaxis of a skin condition in a subject
AU2003240174A8 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
ZA200710476B (en) Methods and compositions for the treatment of pain
IL162492A0 (en) Use of alkylphosphocholines for the preventative treatment of protozoandiseases

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished